{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:39:34Z","timestamp":1770676774811,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014392","name":"Avid Radiopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neurobiolaging.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:06:02Z","timestamp":1565748362000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-8389","authenticated-orcid":false,"given":"Thomas","family":"Desmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Delrieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Lebouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Chlo\u00e9","family":"Balageas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Surget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Belzung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Arlicot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Joao","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Payoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam","family":"El-Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-221X","authenticated-orcid":false,"given":"Vincent","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","article-title":"Benzodiazepine misuse in the elderly: risk factors, consequences, and management","volume":"18","author":"Airagnes","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib2","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/mp.2017.142","article-title":"Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation","volume":"23","author":"Akwa","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2015.07.007","article-title":"Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases","volume":"154","author":"Arbo","year":"2015","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","article-title":"Is there really a link between benzodiazepine use and the risk of dementia?","volume":"14","author":"Billioti de Gage","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.biopsych.2017.11.031","article-title":"The emerging relationship between interstitial fluid-cerebrospinal fluid exchange, amyloid-\u03b2, and sleep","volume":"83","author":"Boespflug","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/gps.4517","article-title":"Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study","volume":"32","author":"Breining","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib9","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0429","article-title":"Impairments of neural circuit function in Alzheimer\u2019s disease","volume":"371","author":"Busche","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/psyg.12239","article-title":"Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study","volume":"17","author":"Chan","year":"2017","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jagp.2016.04.013","article-title":"Benzodiazepine use attenuates cortical \u03b2-amyloid and is not associated with progressive cognitive decline in nondemented elderly adults: a pilot study using F18-florbetapir positron emission tomography","volume":"24","author":"Chung","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-beta in\u00a0vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in\u00a0vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1212\/WNL.0000000000002235","article-title":"Relationship of regional brain \u03b2-amyloid to gait speed","volume":"86","author":"Del Campo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F 18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib17","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib18","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In\u00a0vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","article-title":"Targeting neural hyperactivity as a treatment to stem progression of late-onset Alzheimer\u2019s disease","volume":"14","author":"Haberman","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case\u2013control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib22","doi-asserted-by":"crossref","first-page":"e22978","DOI":"10.7554\/eLife.22978","article-title":"Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline","volume":"6","author":"Leal","year":"2017","journal-title":"ELife"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.dadm.2015.11.003","article-title":"Sensitivity of composite scores to amyloid burden in preclinical Alzheimer\u2019s disease: introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score","volume":"2","author":"Lim","year":"2016","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease","volume":"136","author":"Minter","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0269881109106927","article-title":"Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics","volume":"24","author":"Nutt","year":"2010","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00259-015-3067-9","article-title":"Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings","volume":"42","author":"Payoux","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12640-014-9478-8","article-title":"Effects of repetitive exposure to anesthetics and analgesics in the Tg2576 mouse Alzheimer\u2019s model","volume":"26","author":"Quiroga","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib28","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib30","doi-asserted-by":"crossref","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3383-10.2010","article-title":"Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer\u2019s disease transgenic mice","volume":"30","author":"Tampellini","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib31","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1523\/JNEUROSCI.2292-09.2009","article-title":"Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations","volume":"29","author":"Tampellini","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib32","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib33","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2174\/138161207781368710","article-title":"Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response","volume":"13","author":"Veenman","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib34","first-page":"13","article-title":"Mapt study: a multidomain approach for preventing Alzheimer\u2019s disease: design and baseline data","volume":"1","author":"Vellas","year":"2014","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2015.01.022","article-title":"Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor","volume":"457","author":"Yamamoto","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1523\/JNEUROSCI.2531-15.2016","article-title":"Attenuation of \u03b2-amyloid deposition and neurotoxicity by chemogenetic modulation of neural activity","volume":"36","author":"Yuan","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.08.008_bib37","doi-asserted-by":"crossref","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: a meta-analysis","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019302866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019302866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:30:55Z","timestamp":1759318255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019302866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":37,"alternative-id":["S0197458019302866"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.08.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}